PDF factsheet
      Z

antithrombotics in percutaneous coronary intervention for MI patients undergoing primary PCI, clinical trials results

enoxaparin versus UFH
ATOLL, 2010
IV enoxaparin
versus
UFH
patients undergoing PCI for acute STEMI open
Follow-up duration: 30 days
Austria, France, Germany, and US
Brieger,
enoxaparin
versus
unfractionated heparin
patients undergoing percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI)

  Options


in first

in second

  Filter